These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Current evidence for focal therapy and partial gland ablation for organ-confined prostate cancer: systematic review of literature published in the last 2 years. Kayano PP; Klotz L Curr Opin Urol; 2021 Jan; 31(1):49-57. PubMed ID: 33196540 [TBL] [Abstract][Full Text] [Related]
4. Ablation energies for focal treatment of prostate cancer. Lodeizen O; de Bruin M; Eggener S; Crouzet S; Ghai S; Varkarakis I; Katz A; Dominguez-Escrig JL; Pahernik S; de Reijke T; de la Rosette J World J Urol; 2019 Mar; 37(3):409-418. PubMed ID: 29943219 [TBL] [Abstract][Full Text] [Related]
5. An update on focal therapy for prostate cancer. Perera M; Krishnananthan N; Lindner U; Lawrentschuk N Nat Rev Urol; 2016 Nov; 13(11):641-653. PubMed ID: 27670618 [TBL] [Abstract][Full Text] [Related]
6. Focal therapy of prostate cancer: energies and procedures. Bozzini G; Colin P; Nevoux P; Villers A; Mordon S; Betrouni N Urol Oncol; 2013 Feb; 31(2):155-67. PubMed ID: 22795500 [TBL] [Abstract][Full Text] [Related]
8. New and Established Technology in Focal Ablation of the Prostate: A Systematic Review. Valerio M; Cerantola Y; Eggener SE; Lepor H; Polascik TJ; Villers A; Emberton M Eur Urol; 2017 Jan; 71(1):17-34. PubMed ID: 27595377 [TBL] [Abstract][Full Text] [Related]
9. Morbidity of focal therapy in the treatment of localized prostate cancer. Barret E; Ahallal Y; Sanchez-Salas R; Galiano M; Cosset JM; Validire P; Macek P; Durand M; Prapotnich D; Rozet F; Cathelineau X Eur Urol; 2013 Apr; 63(4):618-22. PubMed ID: 23265382 [TBL] [Abstract][Full Text] [Related]
20. Focal prostate cancer therapy in the era of multiparametric MRI: a review of options and outcomes. Heard JR; Naser-Tavakolian A; Nazmifar M; Ahdoot M Prostate Cancer Prostatic Dis; 2023 Jun; 26(2):218-227. PubMed ID: 35246609 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]